BECN1 and non-small cell lung carcinoma: In NSCLC cells with sensitive EGFR mutations, EGFR kinase inhibitors can trigger autophagy by disrupting tyrosine phosphorylation of Beclin-1, leading to enhanced tumor growth and resistance to TKI treatment (273).